11
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Comparative Contraceptive Efficacy and Mechanism of Action of the Norgestimate-Containing Triphasic Oral Contraceptive

, , , &
Pages 9-14 | Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Giovanni Grandi, Maria Chiara Del Savio & Fabio Facchinetti. (2021) The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism. Expert Review of Clinical Pharmacology 14:2, pages 211-224.
Read now
Carlo Bastianelli, Manuela Farris, Elena Rosato, Ivo Brosens & Giuseppe Benagiano. (2018) Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation. Expert Review of Clinical Pharmacology 11:11, pages 1085-1098.
Read now
Diana Mansour, Pirjo Inki & Kristina Gemzell-Danielsson. (2010) Efficacy of contraceptive methods: A review of the literature. The European Journal of Contraception & Reproductive Health Care 15:1, pages 4-16.
Read now
H. Ferguson, M. L. Vree, J. Wilpshaar & T. K. A. B. Eskes. (2000) Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive. The European Journal of Contraception & Reproductive Health Care 5:1, pages 35-45.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.